(Q24245739)

1

0 references

K Schroeder

2

0 references

T J Peters

3

0 references

T Fahey

Cochrane Database of Systematic Reviews

4

0 references

language of work or name

English

0 references

publication date

2004

0 references

published in

0 references

issue

4

0 references

page(s)

CD004371

0 references

cites work

Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Does a fixed physician reminder system improve the care of patients with coronary artery disease? A randomized controlled trial

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Factors involved in deciding to start preventive treatment: qualitative study of clinicians' and lay people's attitudes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Clinical medication review by a pharmacist of patients on repeat prescriptions in general practice: a randomised controlled trial.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Patient adherence and medical treatment outcomes: a meta-analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Review: multidisciplinary disease management programmes do not reduce death or recurrent myocardial infarction but reduce admission to hospital

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Patient adherence to treatment: three decades of research. A comprehensive review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Pharmacological interventions in type 2 diabetes: the role of nurses

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Goal attainment and maintenance of serum cholesterol level in a pharmacist-coordinated lipid clinic.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Intensive surveillance and treatment of dyslipidemia in the postinfarct patient: evaluation of a nurse-oriented management approach.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Enhancing drug compliance in lipid-lowering treatment

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Impact of pharmacists providing a prescription review and monitoring service in ambulatory care or community practice

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Subgroup analysis and other (mis)uses of baseline data in clinical trials

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Cholesterol management: an opportunity for nurse case managers

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Comprehensive cardiac rehabilitation improves the control of dyslipidemia in secondary prevention.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Automated telephone conversations to assess health behavior and deliver behavioral interventions.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

The physician and pharmacist team. An effective approach to cholesterol reduction

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Role of patient compliance in clinical pharmacokinetics. A review of recent research

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Identifying relevant studies for systematic reviews

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Clinical trials of patient education for chronic conditions: a comparative meta-analysis of intervention types

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

The problem of compliance to cholesterol altering therapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

In people with no evidence of cardiovascular disease, how effective are interventions aimed at controlling risk factors in reducing all-cause and coronary artery disease mortality?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Compliance with fluvastatin treatment characterization of the noncompliant population within a population of 3845 patients with hyperlipidemia. CREOLE Study Team

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

A randomized controlled trial of a physician-directed treatment program for low-income patients with high blood cholesterol: the Southeast Cholesterol Project

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Physician extenders for cost-effective management of hypercholesterolemia.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Efficacy and compliance with cholestyramine bar versus powder in the treatment of hyperlipidemia.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Medication compliance and serum lipid changes in the Helsinki Heart Study

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial.

30 May 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Attaining United Kingdom-European Atherosclerosis Society low-density lipoprotein cholesterol guideline target values in the Greek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Nurse-mediated cholesterol management compared with enhanced primary care in siblings of individuals with premature coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

An intervention to increase physicians' use of adherence-enhancing strategies in managing hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Daily dosing versus alternate-day dosing of simvastatin in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

A case-management system for coronary risk factor modification after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

A comparison of education methods and their impact on behavioral change in patients with hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

The cost effectiveness of lipid lowering in Swedish primary health care. The CELL Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Follow-up care in general practice of patients with myocardial infarction or angina pectoris: initial results of the SHIP trial. Southampton Heart Integrated Care Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Determinants of non-compliance with lipid-lowering therapy in hyperlipidemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Effectiveness of the electronic medical record in cholesterol management in patients with coronary artery disease (Virtual Lipid Clinic).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

A telephone-delivered intervention for patients with NIDDM. Effect on coronary risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Estimating the power of compliance-improving methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

A lipid trial tracking system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Effect of early telephone and postal reminders on medication compliance with pravastatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Teaching patients to monitor their risk factors retards the progression of vascular complications in high-risk patients with Type 2 diabetes mellitus--a randomized prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Electronic monitoring of compliance to lipid-lowering therapy in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Effectiveness of a planned strategy using cardiac rehabilitation nurses for the management of dyslipidemia in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Coaching patients with coronary heart disease to achieve the target cholesterol: a method to bridge the gap between evidence-based medicine and the "real world"--randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Compliance becomes concordance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Adherence to long-term therapies: recent WHO report provides some answers but poses even more questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Poor adherence with hypolipidemic drugs: a lost opportunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004371.PUB2

Nurse case management of hypercholesterolemia in patients with coronary heart disease: results of a randomized clinical trial

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Improving compliance in your dyslipidemic patient: an evidence-based approach.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

A pharmacy-based approach to cholesterol management.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

[Therapeutic compliance in dyslipidemias. A trial of the efficacy of health education].

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

A comparison of fluvastatin 40 mg every other day versus 20 mg every day in patients with hypercholesterolemia

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Effect of pharmaceutical care on optimum colestipol treatment in elderly hypercholesterolemic veterans

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Use and outcomes of a cholesterol-lowering intervention for rural elderly subjects.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163627

Evidence based strategies for secondary prevention of ischaemic heart disease: time to improve clinical practice

29 November 2018

1 reference

12 December 2020

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

1 reference

12 December 2020

Low-density-lipoprotein cholesterol in patients treated by a lipid clinic versus a primary care clinic

1 reference

12 December 2020

Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Effects of "group detailing" on the prescribing of lipid-lowering drugs: a randomized controlled trial in Swedish primary care

1 reference

12 December 2020

The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group

1 reference

12 December 2020

Failure of educational videotapes to improve medication compliance in a health maintenance organization

1 reference

12 December 2020

Changes in cardiovascular risk factors by combined pharmacological and nonpharmacological strategies: the main results of the CELL Study

1 reference

12 December 2020

Alternative therapy use and adherence to antihyperlipidemic drugs in a lipid clinic

1 reference

12 December 2020

Telephone contacts do not improve adherence to niacin or bile acid sequestrant therapy

1 reference

12 December 2020

[The validity of 6 indirect methods for assessing compliance with pharmacological treatment in dyslipidemias]

1 reference

12 December 2020

Effectiveness of interventions to improve patient compliance: a meta-analysis

1 reference

12 December 2020

Treating hyperlipidemia

1 reference

12 December 2020

Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease

1 reference

12 December 2020

Poor compliance: the hidden risk factor

1 reference

12 December 2020

Comparison of the digoxin marker with capsule counting and compliance questionnaire methods for measuring compliance to medication in a clinical trial

1 reference

12 December 2020

Persistence of use of lipid-lowering medications: a cross-national study

1 reference

12 December 2020

[Life style changes in patients with myocardial infarct in the framework of intramural and ambulatory rehabilitation--results of a German pilot study]

1 reference

12 December 2020

Long-term persistence in use of statin therapy in elderly patients

1 reference

12 December 2020